$TACT

TRANSACT TECHNOLOGIES INC

CIK:0001017303|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Net sales	$ 13,948	$ 13,798	$ 28,363	$ 26,851
Cost of sales	6,946	7,146	14,108	13,840
Gross profit	7,002	6,652	14,255	13,011
Operating expenses:
Engineering, design and product development	1,226	1,725	2,606	3,360
Selling and marketing	2,736	2,103	4,933	4,188
General and administrative	3,094	3,082	5,999	5,736
Operating expenses	7,056	6,910	13,538	13,284
Operating (loss) income	(54)	(258)	717	(273)
Interest and other income (expense):
Interest, net	59	40	125	62
Other, net	(25)	115	(73)	178
Interest and other income (expense)	34	155	52	240
(Loss) income before income taxes	(20)	(103)	769	(33)
Income tax expense	(30)	(40)	(53)	(91)
Net (loss) income	$ (50)	$ (143)	$ 716	$ (124)
Net (loss) income per common share:
Basic (in dollars per share)	$ 0	$ (0.01)	$ 0.07	$ (0.01)
Diluted (in dollars per share)	$ 0	$ (0.01)	$ 0.07	$ (0.01)
Shares used in per-share calculation:
Basic (in shares)	10,289	10,085	10,234	10,064
Diluted (in shares)	10,289	10,085	10,311	10,064

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ 716	$ (124)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Share-based compensation expense	966	773
Depreciation and amortization	296	344
Unrealized foreign currency transaction losses (gains)	69	(169)
Changes in operating assets and liabilities:
Accounts receivable	(4,018)	(1,237)
Inventories	1,730	3,360
Prepaid income taxes	(26)	(10)
Other current and long-term assets	(558)	174
Accounts payable	1,474	(646)
Accrued liabilities, deferred revenue and other liabilities	560	969
Net cash provided by operating activities	1,209	3,434
Cash flows from investing activities:
Capital expenditures	(137)	(29)
Capitalized software development costs	(1,973)	0
Net cash used in investing activities	(2,110)	(29)
Cash flows from financing activities:
Withholding taxes paid on stock issuances	(93)	(50)
Net cash used in financing activities	(93)	(50)
Effect of exchange rate changes on cash and cash equivalents	(52)	(3)
(Decrease) increase in cash and cash equivalents	(1,046)	3,352
Cash and cash equivalents, beginning of period	20,433	14,394
Cash and cash equivalents, end of period	19,387	17,746
Supplemental schedule of non-cash investing and financing activities:
Non-cash capital expenditure items	35	21
Right of use asset obtained in exchange for new operating lease liabilities	$ 3,029	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 19,387	$ 20,433
Accounts receivable, net of allowance for expected credit losses of $476 and $476	10,359	6,364
Inventories	9,094	10,858
Prepaid income taxes	424	399
Other current assets	1,298	754
Total current assets	40,562	38,808
Fixed assets, net of accumulated depreciation of $18,793 and $18,519	1,099	1,243
Right-of-use assets, net of accumulated amortization of $1,246 and $1,918	3,209	557
Goodwill	2,621	2,621
Intangible assets, net of accumulated amortization of $1,606 and $1,606	3,476	1,503
Other assets	55	37
Total noncurrent assets	10,460	5,961
Total assets	51,022	44,769
Current liabilities:
Revolving loan payable	3,000	3,000
Accounts payable	5,034	3,539
Accrued liabilities	4,907	4,763
Lease liabilities	506	346
Deferred revenue	1,850	1,400
Total current liabilities	15,297	13,048
Deferred revenue, net of current portion	292	355
Lease liabilities, net of current portion	2,724	215
Other liabilities	34	35
Total noncurrent liabilities	3,050	605
Total liabilities	18,347	13,653
Commitments and contingencies (see Notes 6 and 9)
Shareholders' equity:
Common stock, $0.01 par value, 20,000,000 shares authorized; 14,369,313 and 14,170,676 shares issued, respectively; 10,324,471 and 10,125,834 shares outstanding, respectively	142	141
Additional paid-in capital	60,697	59,824
Retained earnings	3,991	3,275
Accumulated other comprehensive loss, net of tax	(45)	(14)
Treasury stock, at cost (4,044,842 shares)	(32,110)	(32,110)
Total shareholders' equity	32,675	31,116
Total liabilities and shareholders' equity	$ 51,022	$ 44,769